Transcatheter Heart Valve Therapy

About Nininger Medical

Nininger Medical is an early-stage, pre-revenue medical device startup focused on innovative solutions for structural heart failure. Founded in 2019, the company is developing patent-pending transcatheter heart valve technology, indicating a minimally invasive therapeutic approach. Its initial development has been funded by an SBIR grant from the National Science Foundation, awarded in December 2020. The company operates in the large and growing structural heart disease market but remains in a pre-clinical or early R&D stage with no disclosed pipeline programs or leadership team.

Therapeutic Areas